1
|
Su X, Wang HJ, Li B, Zhou MF, Duan YC, Jiang KY, Wang AQ, Wang R, Cao YS. [Characteristics of SPECT/CT-derived pulmonary perfusion imaging in chronic pulmonary vascular stenosis with different etiologies]. Zhonghua Xin Xue Guan Bing Za Zhi 2023; 51:970-976. [PMID: 37709714 DOI: 10.3760/cma.j.cn112148-20230611-00343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/16/2023]
Abstract
Objective: To explore the characteristics of pulmonary blood flow perfusion imaging of single photo emission computer tomography/computer tomography (SPECT/CT) in chronic pulmonary vascular Stenosis (CPVS) caused by different etiological factors. Methods: This is a retropective study. Present study screened 50 consecutive cases diagnosed with chronic pulmonary vascular stenosis from January 2019 to January 2020 in the department of cardiology of Gansu Provincial Hospital and underwent SPECT/CT pulmonary blood flow perfusion examination. Thirteen patients were excluded because of pulmonary vascular lesions with a disease course of less than 3 months and poor image quality. According to the etiology, patients were divided into fibrosing mediastinitis (FM) group, Takyasu's arteritis (PTA) group, and chronic thromboembolic pulmonary hypertension/chronic thromboembolic pulmonary disease (CTEPH/CTED) group. The severity of pulmonary blood flow perfusion was evaluated in accordance with the Begic scoring principle in the three groups. The overall Begic score, lung lobe scores among three groups were compared. CT signs of lung SPECT/CT, such as enlargement of hilar lymph node, atelectasis, bronchial stenosis, were also analyzed in three groups. Results: A total of 37 patients with chronic pulmonary vascular stenosis were finally enrolled (18 in the FM group, 5 in the PTA group, and 14 in the CTEPH/CTED group). The total Begic score of pulmonary perfusions was similar among the three groups (F=0.657,P>0.05). There was a statistically significant difference in the left upper lobe Begic score among the three groups (H=4.081, P<0.05). The left upper lobe Begic score was higher in the FM group than in the PTA group (3.44±2.50 vs. 1.60±0.55, P<0.05). As compared to other two groups, patients in FM group were featured with CT signs of higher percent of hilar enlargement (FM group vs. PTA group: 16/18 vs. 1/5, P=0.008; FM group vs. CTEPH/CTED group: 16/18 vs. 3/14, P=0.000 2), enlargement of the pulmonary hilum lymph nodes (FM group vs. PTA group: 14/18 vs. 1/5, P=0.033; FM group vs. CTEPH/CTED group: 14/18 vs. 2/14, P=0.001), and calcification of mediastinal soft tissue (FM group vs. PTA group: 11/18 to 0/5, P=0.037; FM group vs. CTEPH/CTED group: 11/18 vs. 1/14, P=0.003). The proportion of CT signs of bronchial stenosis (9/18 vs. 0/14, P=0.002) and atelectasis (9/18 vs. 1/14, P=0.002) was also higher in the FM group than in the CTEPH/CTED group. In case of abnormal pulmonary blood flow perfusion, the diagnostic accuracy of CT signs hilar enlargement, hilar lymph node enlargement, mediastinal soft tissue calcification, bronchial stenosis, and atelectasis for the diagnosis of FM were 81.1%, 83.8%, 78.4%, 75.7%, and 73.0%, respectively. Conclusion: There is no significant difference in the Begic score of SPECT/CT pulmonary blood flow perfusion imagines among the three groups of patients. Impaired pulmonary blood flow perfusion combined with typical CT signs is useful for identifying patients with FM.
Collapse
Affiliation(s)
- X Su
- Department of Nuclear Medicine, Gansu Provincial Hospital, Lanzhou 730000, China
| | - H J Wang
- Department of Nuclear Medicine, Gansu Provincial Hospital, Lanzhou 730000, China
| | - B Li
- Department of Cardiology, Pulmonary Vascular Disease Center, Gansu Provincial Hospital, Lanzhou 730000, China
| | - M F Zhou
- The First Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
| | - Y C Duan
- Department of Cardiology, Xianyang Central Hospital, Xianyang 712000, China
| | - K Y Jiang
- Department of Cardiology, Pulmonary Vascular Disease Center, Gansu Provincial Hospital, Lanzhou 730000, China
| | - A Q Wang
- Department of Cardiology, Pulmonary Vascular Disease Center, Gansu Provincial Hospital, Lanzhou 730000, China
| | - R Wang
- Department of Nuclear Medicine, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y S Cao
- Department of Cardiology, Pulmonary Vascular Disease Center, Gansu Provincial Hospital, Lanzhou 730000, China
| |
Collapse
|
2
|
Duan YC, Su HL, Wei R, Jiang KY, Wang AQ, Yang YH, Pan X, Zhang Y, Cao YS. [Short-term efficacy and perioperative safety of catheter-based intervention for pulmonary vein stenosis caused by fibrosing mediastinitis]. Zhonghua Xin Xue Guan Bing Za Zhi 2022; 50:55-61. [PMID: 35045615 DOI: 10.3760/cma.j.cn112148-20210507-00398] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To evaluate the short-term efficacy and perioperative safety of catheter-based intervention in patients with pulmonary vein stenosis caused by fibrosing mediastinitis (FM). Methods: It was a case series study. Consecutive patients with pulmonary vein stenosis caused by FM, who underwent percutaneous pulmonary vein angioplasty in Gansu Provincial Hospital from January 2018 to June 2020, were retrospective enrolled. The baseline characteristics, comorbidities, exercise capacity and hemodynamic data before and after treatment were compared, and the procedural related complications were evaluated. Results: A total of 30 patients ((64.3±7.1) years, 15 males) were included. Sixty-three pulmonary vein stenosis were treated by 32 percutaneous pulmonary vein angioplasty procedures. Forty-four stents were implanted in 41 pulmonary veins after balloon angioplasty, and the diameter of implanted stents was (8.3±1.2)mm. Balloon angioplasty was performed on 22 pulmonary vein stenosis, the mean balloon diameter was (4.2±2.1)mm. The pulmonary vein diameter increased from (2.6±1.3) to (6.6±2.6) mm (P<0.001) and the pressure gradient across the pulmonary vein stenotic segment reduced from 19 (12, 29) to 2 (0, 4) mmHg (1 mmHg=0.133 kPa) (P<0.001) immediately post procedure. The pulmonary vein flow grade was significantly improved compared with baseline (P<0.001). The most common operation related complications were lung injury (44.0% (11/25)) and hemoptysis (18.8% (6/32)), which did not need special treatment. During the 2.0 (1.3, 3.2) months follow-up, the WHO functional class was significantly improved (P<0.05), the 6-minute walking distance increased from (254.8±114.5) m to (342.8±72.4)m (P<0.05), the mean pulmonary arterial pressure decreased from (40.9±8.3) mmHg to (35.4±7.7) mmHg (P<0.01), 17 out of 19 patients with refractory pleural effusion experienced total remission during the follow-up period (P<0.001). CT pulmonary venography was repeated in 17 patients. The incidence of in-stent restenosis of pulmonary vein was 24.0% (6/25). Conclusions: Percutaneous pulmonary vein angioplasty is effective for the treatment of pulmonary vein stenosis caused by fibrosing mediastinitis. However, it's not so safe, procedural related complication should be paid attention to and the rate of in-stent restenosis is relative high during the short-term follow-up.
Collapse
Affiliation(s)
- Y C Duan
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - H L Su
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - R Wei
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - K Y Jiang
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - A Q Wang
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y H Yang
- Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - X Pan
- Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China
| | - Y Zhang
- Tianjin Medical University Eye Hospital, Translational Medicine Laboratory, Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin 300384, China
| | - Y S Cao
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| |
Collapse
|
3
|
Cao YS, Duan YC, Su HL. [Advances in diagnosis and therapy of pulmonary vascular stenosis induced by fibrosing mediastinitis]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:823-830. [PMID: 33076618 DOI: 10.3760/cma.j.cn112148-20200214-00081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- Y S Cao
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y C Duan
- Department of Cardiology, Xianyang Central Hospital, Xianyang 712000, China
| | - H L Su
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| |
Collapse
|
4
|
Zhou X, Li YJ, Cao YS, Su HL, Duan YC, Su X, Wei R, Chu AA, Zhu Y, Huang Y, Zhang M, Pan X. [Feasibility and efficacy of percutaneous pulmonary vein stenting for the treatment of patients with severe pulmonary vein stenosis due to fibrosing mediastinitis]. Zhonghua Xin Xue Guan Bing Za Zhi 2019; 47:814-819. [PMID: 31648464 DOI: 10.3760/cma.j.issn.0253-3758.2019.10.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the feasibility and safety percutaneous pulmonary vein intervention in patients with severe pulmonary vein stenosis (PVS) caused by fibrosing mediastinitis(FM). Methods: This retrospective analysis included 5 FM patients (2 male, 3 female, 54-77 years old) confirmed by clinical presentation and chest computed tomography (CT) scan from January to June 2018 who were from Gansu Provincial Hospital and Shanghai Chest Hospital. CT pulmonary angiography (CTPA) further revealed severe PVS caused by fibrotic tissue compression in mediastinum. After selective pulmonary vein angiography, gradually balloon angioplasty was used to expand the pulmonary vein and then stents were implanted in the pre-dilated stenotic pulmonary veins. Evaluation of therapeutic effect was made at 6 months after the procedure. Results: All of 11 serious compression PVS were treated with stent implantation (diameter: 7-10 mm, length: 17-27 mm). After stenting, degree of pulmonary vein stenosis decreased from (83±16)% to (12±4)% (P<0.01). The minimal diameter of the stenotic pulmonary vein was significantly increased from (0.8±0.5)mm to (7.5±0.8)mm (P<0.01). Trans-stenotic gradient decreased from (27.0±15.1)mmHg (1 mmHg=0.133 kPa) to (2.50±0.58)mmHg (P<0.05). Mean pulmonary pressure measured by cardiac catheter decreased from (45.0±9.0)mmHg to (38.7±8.4)mmHg (P<0.05). One patient experienced cardiac arrest due to vagal nerve reflex during big sizing balloon stent dilation and recovered after cardiopulmonary resuscitation. There were no other serious procedure related complications. During the follow-up, severe stenosis at end of proximal stent was evidenced in 1 patient due to fibrotic compression, and another patient developed in-stent thrombosis due to discontinuation of prescribed anticoagulant. Conclusion: Percutaneous intervention for severe pulmonary vein stenosis caused by FM is feasible and safe, and can improve hemodynamic caused by the compression of mediastinal vascular structures in these carefully selected patients.
Collapse
Affiliation(s)
- X Zhou
- Department of Radiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y J Li
- Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China
| | - Y S Cao
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - H L Su
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y C Duan
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - X Su
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - R Wei
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - A A Chu
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y Zhu
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - Y Huang
- Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - M Zhang
- Department of Pathology, Gansu Provincial Hospital, Lanzhou 730000, China
| | - X Pan
- Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China
| |
Collapse
|
5
|
Zhao YM, Duan YC, Zhu JL, Ding HY, Shan Y, Zhu ZP. [Correlation between the expression of STOX1 in placenta of patients with early onset preeclampsia]. Zhonghua Yi Xue Za Zhi 2019; 99:1664-1668. [PMID: 31189268 DOI: 10.3760/cma.j.issn.0376-2491.2019.21.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the relationship of STOX1expression and pathogenesis of early onset preeclampsia. Methods: 65 cases of preeclampsia women who delivered in Shanghai Pudong Hospital from October 2015 to June 2018, were recruited, which included 31 cases with early onset preeclampsia (early onset group, gestational week<34 weeks) and 34 patients with late onset preeclampsia (late onset group, gestational week ≥34 weeks). 34 cases women who received caesarean section because of pelvic structural deformities, breech presentation, macrosomia and social factors were included as the control group(gestational week ≥34 weeks) were selected as control group.The expression and localization of STOX1 mRNA and protein in placenta of three groups of maternal were evaluated by immunohistochemistry SP, RT-qPCR and Western blotting. Results: (1) The expression of STOX1 in placenta mainly distributed in the cytoplasm of placental syncytiotrophoblasts, cytotrophoblasts, vascular endothelial and mesenchymal cells, a few in the cell nucleus.The staining intensity of STOX1 in early onset group was significantly stronger than that in late onset group, the staining intensity of the late onset group was similar to that of the control group. The positive expression rates of STOX1protein in early onset group, late onset group and control group were 96.8%(30/31), 70.6%(24/34), 67.6%(23/34) respectively, which was higher in early onset group than that in late onset group(P=0.005). There was no statistical difference of STOX1 level between the late onset group and the control group(P=0.793). (2)Relative expression of STOX1 mRNA in early onset group, late onset group and control group were 0.054 3±0.003 5,0.037 5±0.000 7,0.035 2±0.000 4 respectively, which was significantly higher in early onset group than that in late onset group(P<0.05), while there was no statistical difference between the late onset group and the control group(P>0.05).(3)Relative expression level of STOX1 protein in early onset group, late onset group and control group were 0.78±0.04,0.59±0.020 and 0.54±0.018 respectively, which is higher in early onset group than that in late onset group(P<0.05). There was no statistical difference of STOX1 level between the late onset group and the control group(P>0.05). Conclusions: The pathogenesis of early onset and late onset preeclampsia may be different. Up-regulated expression of STOX1 in placenta may be associated with the pathogenesis of early onset preeclampsia.
Collapse
Affiliation(s)
- Y M Zhao
- Department of Gynecology and Obstetrics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China
| | | | | | | | | | | |
Collapse
|
6
|
Zhao YM, Ding HY, Hu H, Duan YC, Zhu JL, Shan Y, Xu YQ, Sun HM, Zang H, Zhu ZP. [Expression and significance of STOX1 in villi and placenta at different stages of normal gestation]. Zhonghua Yi Xue Za Zhi 2019; 99:1003-1007. [PMID: 30955313 DOI: 10.3760/cma.j.issn.0376-2491.2019.13.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the expression and significance of STOX1 in different stages of gestation villi and placenta. Methods: Totally 137 cases of normal villi and placenta of pregnant women were collected from the Department of Obstetrics of Shanghai Pudong Hospital from October 1(st) 2015 to February 28(th) 2018, including 64 cases of early pregnancy (early pregnancy group) which consists of 32 cases of 5-7(+6) weeks gestation (early pregnancy group A) and 32 cases of 8-11(+3) weeks gestation (early pregnancy group B), 28 cases of 14-26 weeks gestation(middle pregnancy group) and 45 cases of 37-41 weeks gestation (late pregnancy group). The expression and localization of STOX1 mRNA and protein in placenta were evaluated by RT-qPCR, Western blotting and immunohistochemistry. Results: (1)STOX1 was positively expressed in the cytotrophoblasts and syncytiotrophoblasts as well as interstitial and vascular endothelial cells of all groups. (2)STOX1 mRNA expression in each group was significantly different (P<0.05), the lowest was in the early pregnancy group A(0.007 8±0.000 4), which increased along with the progression of gestational age(P<0.05),and reached the highest level in the third trimester(0.064 4±0.001 3). (3)The protein level of STOX1 in different stages of normal pregnancy was 0.53±0.20 in early pregnancy group A;0.62±0.37 in early pregnancy group B;0.70±0.03 in middle pregnancy group and 0.81±0.04 in late pregnancy group respectively; which was positively related with the progression of gestational age (P<0.05). Conclusion: The expressions of STOX1 is gradually increasing along with the normal pregnancy progression, suggesting that it might be involved in proliferation, differentiation and infiltration and (or) apoptosis of trophoblast cells and the development of the placenta.
Collapse
Affiliation(s)
- Y M Zhao
- Department of Gynecology and Obstetrics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Cao TM, Han HN, Duan YC. [Clinical study on long-term treatment of ankylosing spondylitis with integrated Traditional Chinese and Western medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001; 21:576-8. [PMID: 12575568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
OBJECTIVE To seek for the new method of integrated traditional Chinese and western medical treatment (TCM-WM) for ankylosing spondylitis (AS) to control the disease development, shorten the therapeutic course and reduce disability rate. METHODS Patients of AS enrolled in this study were 106 patients in group A, who were persistently treated with TCM-WM for over 10 months, 48 patients in group B treated with western medicine and 34 in group C treated with non-steroidal anti-inflammatory and analgesic agents. They were followed-up for 2 years. RESULTS (1) Short-term effect: the markedly effective rate in the three groups was 73.58%, 47.92% and 5.88% respectively, and the total effective rate was 96.23%, 87.50% and 41.18% respectively. The comparisons of group A to group B and C showed significant difference, the effect in group A was superior to that in group B and group C (chi 2 = 10.58, P < 0.01 and chi 2 = 67.76, P < 0.01 respectively). (2) Results of 2-year follow-up: the recurrence rate in group A was 18.37% (9/49), it was insignificantly different from that in group B (7/23 = 30.43%, chi 2 = 1.32, P > 0.05), but significantly different from that in group C (8/12 = 66.67%, chi 2 = 11.19, P < 0.01). CONCLUSION Long-term TCM-WM therapy, which concentrated on the advantages of traditional Chinese and western medicine, was a practical method in treating AS with reliable effect, few side-reaction, therefore, is worth spreading.
Collapse
Affiliation(s)
- T M Cao
- 208th Hospital of PLA, Changchun 130062
| | | | | |
Collapse
|